OTC Markets Stock News
Biotech
-
4.5KElite Pharmaceuticals, Inc. (OTCMKTS: ELTP) A Breakout Play On Sales Growth Boost
Elite Pharmaceuticals, Inc. (OTCMKTS: ELTP) stock has been on an impressive run ever since the company reported impressive financial results for the...
-
3.5KPharmacyte Biotech Inc (OTCMKTS: PMCB) Is A Discount Entry Opportunity
The tide is starting to change after a harrowing plunge that saw Pharmacyte Biotech Inc (OTCMKTS: PMCB) shed a significant amount of...
-
4.6KPredictive Technology Group Inc (OTCMKTS: PRED): A Buy On Improving Fundamentals
Predictive Technology Group Inc (OTCMKTS: PRED) is an exciting bounce back play after a steep pullback from all-time highs. While the stock...
-
1.8KPredictive Technology Group Inc (OTCMKTS: PRED) Is A Buy On Dips
Predictive Technology Group Inc (OTCMKTS: PRED) is flying higher after reporting a tenth consecutive quarter of revenue growth. The Company achieving significant...
-
1.9KCan Soliton Inc (NASDAQ: SOLY) Sustain The Rally?
On May 28, Soliton Inc (NASDAQ:SOLY) surged 81% while the volume traded was up 16x. In particular, the rally came on the...
-
4.3KOWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Primed For Gains After Bottoming Out
OWC Pharmaceutical Research Corp (OTCMKTS: OWCP) is a potential bounce-back play as alluded in our previous update. After hitting bottom, the stock...
-
1.7KAnavex Life Sciences Corp (NASDAQ:AVXL) Eyes Further Gains After Breakout
In true fashion and as predicted, 2019 is turning out to be a big year for Anavex Life Sciences Corp (NASDAQ: AVXL)....
-
1.2K2AngioSoma Inc (OTCMKTS: SOAN) Bounces Back
A lot has been happening lately at AngioSoma Inc (OTCMKTS: SOAN), including a tumbling stock affected by weak investor sentiment. However, the...
-
1.1KFrélii, Inc. (OTCMKTS:FRLI) Bounce Back Likely
Frélii, Inc. (OTCMKTS: FRLI) market prospects have turned from bad to worse as investor sentiments edge lower. The stock has lost more...
-
997CytoDyn Inc (OTCMKTS: CYDY) Plotting A Comeback
CytoDyn Inc (OTCMKTS: CYDY) stock has posted impressive gains ever since the biotechnology company posted preclinical data showing its candidate drug Leronlimab...
